Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Daily News

Aspirin as Secondary Prevention Still Subpar, Especially in Lower-Income Countries

Caitlin E. Cox

August 24, 2023

News Daily News

TCTMD’s Michael O’Riordan Wins Digital Health Award

Shelley Wood

August 22, 2023

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Daily News

Discharge Safe as Early as a Day After Primary PCI for STEMI

L.A. McKeown

December 15, 2021

News Daily News

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Michael O'Riordan

June 18, 2021

News Conference News ACC 2021

Poorer Neighborhoods Pose Risks for Black Patients After Acute MI

L.A. McKeown

May 05, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Daily News

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

Shelley Wood

May 29, 2020

News Daily News

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

Shelley Wood

May 22, 2020

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Shelley Wood

April 29, 2020

News Features

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

Shelley Wood

April 02, 2020

News Daily News

PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching

Shelley Wood

February 19, 2020

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Daily News

FDA Is Surveilling Heparin but Believes Defective Quality Unlikely

Yael L. Maxwell

December 06, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

Shelley Wood

August 30, 2019

Advertisement

Use of Secondary CVD Prevention Meds Still Meager Worldwide

April 2024 Dispatch for the CV Team

Aspirin as Secondary Prevention Still Subpar, Especially in Lower-Income Countries

TCTMD’s Michael O’Riordan Wins Digital Health Award

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

January 2022 News Roundup

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Discharge Safe as Early as a Day After Primary PCI for STEMI

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Poorer Neighborhoods Pose Risks for Black Patients After Acute MI

TCTMD’s Top 10 Most Popular Stories for October 2020

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

FDA Is Surveilling Heparin but Believes Defective Quality Unlikely

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

TCTMD’s Top 10 Most Popular Stories for August 2019

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content